GW Pharmaceuticals Stock Initially Pops, Then Dives, After CBD Oil Gains Approval In Europe - Investor's Business Daily
GW Pharmaceuticals Stock Initially Pops, Then Dives, After CBD Oil Gains Approval In Europe Investor's Business DailyGW Pharmaceuticals stock ultimately slipped Monday after European regulators approved the biotech company's CBD oil in two seizure disorders.